CD28 and neoplasm: As shown in Fig. 8b, we found that PD-1 ablation enhanced the anti-tumor efficacy of LA but not HA HER2 CAR-T cells in mice containing SKOV3 wild-type tumors, consistent with our earlier findings in CD28-based CAR-T cells.